Skip to main content
Download PDF

Retraction Note to: Methylene blue photochemical treatment as a reliable SARS-CoV-2 plasma virus inactivation method for blood safety and convalescent plasma therapy for COVID-19

BMC Infectious Diseases volume 21, Article number: 672 (2021) Cite this article

The Original Article was published on 16 April 2021

Retraction Note: BMC Infect Dis 21, 357 (2021)

https://doi.org/10.1186/s12879-021-05993-0

The editor has retracted this article. Following publication concerns were raised regarding Fig. 1, specifically:

  • The Light 0 min panel for Virus Control appears to partially overlap with the Light 0 min panel for 1uM MB No light.

  • The Light 0 min panel for 1um MB No light appears to partially overlap with the Light 40 Min panel of the same row, and partially overlap with the Light 0 Min panel for No MB.

In addition, the authors Bin Yu, Jie Zhang, Hao Wu, Xipeng Zhou and Miao Jiang did not appropriately declare a competing interest regarding their affiliation with Boxin (Beijing) Biotechnology Development LTD and its product ‘BX-1 AIDS treatment instrument’ as described in this article.

The editor therefore no longer has confidence in the reliability of the data reported in the article.

Changzhong Jin, Bin Yu, Jie Zhang, Hangping Yao, Fumin Liu, Xiangyun Lu, Linfang Cheng, Miao Jiang and Nanping Wu do not agree to this retraction. Hao Wu and Xipeng Zhou have not responded to any correspondence from the editor about this retraction.

Author information

Author notes

  1. Changzhong Jin, Bin Yu and Jie Zhang contributed equally to this work.

Affiliations

  1. State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Disease, National Medical Center for Infectious Disease, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China

    Changzhong Jin, Hangping Yao, Fumin Liu, Xiangyun Lu, Linfang Cheng & Nanping Wu

  2. Boxin (Beijing) Biotechnology Development LTD, 4/F, Tower B, Siemens Building, No. 7 South Central Road, Wangjing, Chaoyang District, Beijing, China

    Bin Yu, Hao Wu, Xipeng Zhou & Miao Jiang

  3. Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, Preventive Medicine Institute, Air force Medical University, Xi’an, China

    Jie Zhang

Authors
  1. Changzhong Jin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bin Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jie Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hao Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xipeng Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hangping Yao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Fumin Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Xiangyun Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Linfang Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Miao Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Nanping Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Bin Yu, Miao Jiang or Nanping Wu.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Jin, C., Yu, B., Zhang, J. et al. Retraction Note to: Methylene blue photochemical treatment as a reliable SARS-CoV-2 plasma virus inactivation method for blood safety and convalescent plasma therapy for COVID-19. BMC Infect Dis 21, 672 (2021). https://doi.org/10.1186/s12879-021-06344-9

Download citation

BMC Infectious Diseases

ISSN: 1471-2334

Contact us